World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00104078
Date of registration: 22/02/2005
Prospective Registration: No
Primary sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Public title: Study Evaluating MYO-029 in Adult Muscular Dystrophy
Scientific title:
Date of first enrolment: February 2005
Target sample size: 108
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00104078
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment  
Phase:  Phase 1/Phase 2
Countries of recruitment
United States
Contacts
Name:     Medical Monitor, MD
Address: 
Telephone:
Email:
Affiliation:  Wyeth is now a wholly owned subsidiary of Pfizer
Key inclusion & exclusion criteria

Inclusion Criteria:

- Written informed consent.

- Confirmed clinical and molecular diagnosis of Becker Muscular Dystrophy (BMD),
Facioscapulohumeral Muscular Dystrophy (FSHD), or Limb-Girdle Muscular Dystrophy
(LGMD)

- Independently ambulatory

Exclusion Criteria:

- Patients with certain clinical conditions

- Patients using steroids or other medications with the potential to affect muscle
function

- History of sensitivity to monoclonal antibodies or protein pharmaceuticals

- Pregnant or lactating women.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Facioscapulohumeral Muscular Dystrophy
Becker Muscular Dystrophy
Limb-Girdle Muscular Dystrophy
Intervention(s)
Drug: MYO-029
Primary Outcome(s)
Safety assessment
Secondary Outcome(s)
Secondary ID(s)
3147K2-101
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history